Vericel Reports 26% Q3 Revenue Growth and Raises Full-Year 2026 Financial Guidance

Vericel Corporation announced its third-quarter 2026 financial results, reporting significant year-over-year growth in revenue and profitability. Driven by strong performance in its MACI and Burn Care segments, the company has raised its full-year 2026 guidance for total revenue and adjusted EBITDA margin.

Key Details

• Q3 2026 Financials: Total revenue increased 26% to $85.4 million compared to Q3 2025. Net income grew 179% to $14.2 million, or $0.27 per diluted share.
• Updated 2026 Guidance: Full-year revenue guidance was raised to $344-$346 million (from $330-$340 million). Adjusted EBITDA margin guidance was increased to 28% (from 27%).
• Segment Performance: MACI revenue grew 21% to $67.4 million, while the Burn Care segment revenue (Epicel and NexoBrid) increased by 52% to $18.0 million.